ProMIS Neurosciences (PMN) Non Operating Income (2021 - 2025)
ProMIS Neurosciences (PMN) recorded Non Operating Income of $98,031 in Q4 2025, down 98.3% from $5.76 million a year earlier and down 42.4% from the prior quarter.
Powered by 
Analysis
ProMIS Neurosciences (PMN) Non Operating Income (2021 - 2025) Analysis & Trends
For FY2025, ProMIS Neurosciences reported Non Operating Income of $448,161, down 97.7% from FY2024.
- Across earlier years, Non Operating Income came in at $19.61 million in FY2024, $1.05 million in FY2023 (-80.2%), $5.32 million in FY2022 and -$1.5 million in FY2021.
- Quarterly Non Operating Income has ranged from $11,240 in Q1 2023 to $13.71 million in Q3 2024 over the past five years.
- On a year-over-year basis, Non Operating Income has declined for three consecutive quarters, with growth averaging 22.2% over the last six quarters.
- Peak year-over-year performance for Non Operating Income in the last five years was growth of 269.8% in Q1 2024, against a decline of 99.4% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $170,306 (Q3 2025), $67,632 (Q2 2025) and $112,192 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | ProMIS Neurosciences | 97.30 Mn | -41.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 98,031.00 |
| Sep 30, 2025 | 170,306.00 |
| Jun 30, 2025 | 67,632.00 |
| Mar 31, 2025 | 112,192.00 |
| Dec 31, 2024 | 5.76 Mn |
| Sep 30, 2024 | 13.71 Mn |
| Jun 30, 2024 | 90,049.00 |
| Mar 31, 2024 | 41,563.00 |
| Dec 31, 2023 | 294,208.00 |
| Sep 30, 2023 | 156,892.00 |
| Jun 30, 2023 | 587,910.00 |
| Mar 31, 2023 | 11,240.00 |
| Dec 31, 2022 | 1.26 Mn |
| Sep 30, 2022 | 97,260.00 |
| Jun 30, 2022 | 2.12 Mn |
| Mar 31, 2022 | 1.84 Mn |
| Dec 31, 2021 | 2.30 Mn |
| Sep 30, 2021 | 860,235.00 |
| Jun 30, 2021 | 879,873.00 |
API Access
ProMIS Neurosciences Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=PMN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "PMN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=PMN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();